Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracochlear Glucocorticoid Injection for Total SSNHL
NCT07134075Phase 2Not yet recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide, dexamethasone in sudden sensorineural hearing loss (SSHL), sponsored by Eye and ENT Hospital of Fudan University. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonidedexamethasone
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07134075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07134075.